Girao Tiagoinsider trades

In SEC Form 4 filings, Girao Tiago is listed as Chief Financial Officer of Immunovant, Inc. (IMVT). In the last 90 days, Girao Tiago sold $188.3K of Immunovant, Inc. (IMVT) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
IMVTImmunovant, Inc.	Chief Financial Officer	1	Oct 30

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-30

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
IMVTImmunovant, Inc.	Oct 28	Oct 30	S	6,606	$28.50	Sale −$188,271	234,192	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.